Which companies are Xuanzhu Biopharmaceutical's closest peers?

The cockpit's peer set: Qingdao Paguld Intelligent Manufacturing (301456.SZ), Premium (7199.T), Hunan SUND Technological (301548.SZ), Zhejiang Zoenn Design (300901.SZ), Xinjiang Baihuacun Pharam Tech (600721.SS), Sichuan Joyou Digital Technologies (301172.SZ), GlobalData (DATA.L), TKP (3479.T).

Is Xuanzhu Biopharmaceutical expensive compared with its peers?

On ev / sales it trades at 31.5× against a peer median of 3.5×, most expensive of 21 in its peer set.

How has Xuanzhu Biopharmaceutical stock performed?

Over six months to 6 Nov 2026 the shares returned -58.6% against -4.5% for the median peer; over one year -86.7%.

← CockpitCompetitor Analysis › 2575.HK Xuanzhu Biopharmaceutical Co., Ltd. Class HOpen in the cockpit ↗

Xuanzhu Biopharmaceutical Co., Ltd. Class H2575.HKCompetitor analysis, valuation and peers

Hong Kong · HKD·Industrials›Miscellaneous Commercial Services

Momentum laggard 13

Competitor Analysis ▸ Charts Open in the cockpit

Mkt cap

$553M

US dollars, full cap

Free float

35%

of shares outstanding

$/day

$2.10M

20-day average traded

Fwd P/E

n/m

no positive forecast

ROIC−WACC

-27.6 pp

WACC 5.8%

Hurdle

n/a

no reverse DCF

Close · HKDHK$8.37

1D-3.3%

1W-2.7%

1M-0.8%

3M-32.9%

6M-58.6%

YTD-88.1%

1Y-86.7%

ATR %8.8%

52w lowhigh91.4% off high

What Xuanzhu Biopharmaceutical does

Employees: 342

Xuanzhu Biopharmaceutical at a glance

Size Xuanzhu Biopharmaceutical (2575.HK) is a Hong Kong Industrials company (Miscellaneous Commercial Services) with a market value of $553M, the 734th largest of 891 Hong Kong companies the cockpit tracks. Shares closed at HK$8.37 on 6 Nov 2026.

Performance Over six months the shares fell 58.6%, against -4.5% for the median peer and -13.4% for the Hong Kong market (cap-weighted) — lowest of 21 in its peer set.

Growth Revenue grew 237.2% over the last twelve months (peer median +15.6%); the operating margin is -186.7% (peer median 9.2%).

Valuation It trades at 31.5× enterprise value to sales against a peer median of 3.5× (most expensive of 21).

Capital Return on invested capital runs 27.6 points below its cost of capital (5.8% WACC).

Relative performance

Six months, rebased to 100: Xuanzhu Biopharmaceutical against the median of its 20 peers (local-currency closes).

Xuanzhu Biopharmaceutical financials

Reported figures in HKD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
	TTM	FY2025	FY2024	FY2023	FY2022
Revenue	HK$116M	HK$56.1M	HK$32.6M	HK$32,045	HK$0
Revenue growth	—	+72%	+101,721%	—	—
Gross profit	HK$52.3M	HK$21.8M	-HK$12.6M	-HK$35.5M	-HK$30.2M
EBITDA	n/a	-HK$221M	-HK$575M	-HK$339M	-HK$550M
Net income	-HK$233M	-HK$266M	-HK$603M	-HK$332M	-HK$596M
Free cash flow	n/a	-HK$224M	-HK$105M	-HK$130M	-HK$501M
Capital expenditure	n/a	HK$46.2M	HK$87.0M	HK$162M	HK$194M
Total debt	n/a	HK$720,638	HK$1.57M	HK$18.8M	HK$32.8M

Quarterly statements and history in the cockpit →

Xuanzhu Biopharmaceutical competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

Up and to the right = strong over both horizons. Xuanzhu Biopharmaceutical is the large dot.

Fundamentals: revenue growth against valuation

Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Xuanzhu Biopharmaceutical is the large dot.

Xuanzhu Biopharmaceutical competitors and peer comparison

How Xuanzhu Biopharmaceutical compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Xuanzhu Biopharmaceutical against its 20 peers (data as of 6 Nov 2026)
Measure	2575.HK	Peer median	Rank in peer set
1-month return	-0.8%	-7.0%	5th highest of 21
6-month return	-58.6%	-4.5%	lowest of 21
Distance from 52-week high	-91.4%	-34.8%	lowest of 21
Revenue growth (TTM)	+237.2%	+15.6%	highest of 21
Operating margin	-186.7%	9.2%	2nd lowest of 21
EV / Sales	31.5×	3.5×	most expensive of 21
ROIC minus cost of capital	-27.6 pp	-0.6 pp	2nd lowest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
Company	Market	Market cap	6M return	Revenue growth	Op. margin	EV / Sales	Req g	Delivered g
Xuanzhu Biopharmaceutical 2575.HK	Hong Kong	$553M	-59%	+237%	-187%	31.5×	n/a	n/a
Qingdao Paguld Intelligent Manufacturing 301456.SZ	China	$555M	-26%	+29%	13%	3.7×	n/a	n/a
Premium 7199.T	Japan	$556M	+18%	+21%	20%	1.2×	-13.1%	+20.6%
Hunan SUND Technological 301548.SZ	China	$557M	-42%	+23%	21%	3.8×	18.4%	+13.8%
Zhejiang Zoenn Design 300901.SZ	China	$549M	-5%	+53%	10%	7.5×	n/a	n/a
Xinjiang Baihuacun Pharam Tech 600721.SS	China	$560M	+15%	-19%	10%	10.8×	36.3%	+36.9%
Sichuan Joyou Digital Technologies 301172.SZ	China	$563M	-40%	+18%	4%	6.0×	57.4%	+6.3%
GlobalData DATA.L	United Kingdom	$564M	-37%	+9%	31%	1.8×	-7.8%	+12.5%
TKP 3479.T	Japan	$538M	+18%	+51%	9%	1.0×	-3.3%	+21.5%
Beijing Telesound Electronics 003004.SZ	China	$568M	+45%	+26%	-1%	10.3×	n/a	n/a
Jiangsu Chuanzhiboke Education Technology 003032.SZ	China	$569M	+43%	+60%	-18%	7.2×	n/a	n/a
Baotou INST Magnetic New Materials 301622.SZ	China	$570M	-40%	+3%	-1%	2.7×	n/a	n/a
SIS SIS.NS	India	$570M	-4%	+25%	3%	0.3×	3.4%	+11.9%
CECEP Techand Ecology and Environment 300197.SZ	China	$571M	+8%	+21%	-271%	14.0×	29.2%	-26.5%
Weathernews 4825.T	Japan	$534M	-11%	+5%	21%	2.8×	3.4%	+5.4%
Restore RST.L	United Kingdom	$534M	+14%	+8%	13%	2.0×	5.5%	+10.8%
Guangdong Brandmax Marketing 300805.SZ	China	$533M	-19%	+13%	1%	1.1×	n/a	n/a
Sporton International 6146.TWO	Taiwan	$531M	-24%	+8%	30%	3.6×	-6.6%	+5.0%
Academy of Environmental Planning & Design Co., Ltd. Nanjing University 300864.SZ	China	$531M	0%	+5%	18%	3.4×	9.3%	+10.6%
Shenzhen Manst Technology 301325.SZ	China	$578M	-38%	-62%	-38%	6.0×	n/a	n/a
Posti POSTI.HE	Finland	$529M	+31%	0%	5%	0.7×	-5.4%	-1.4%

Questions

Which companies are Xuanzhu Biopharmaceutical's closest peers?: The cockpit's peer set: Qingdao Paguld Intelligent Manufacturing (301456.SZ), Premium (7199.T), Hunan SUND Technological (301548.SZ), Zhejiang Zoenn Design (300901.SZ), Xinjiang Baihuacun Pharam Tech (600721.SS), Sichuan Joyou Digital Technologies (301172.SZ), GlobalData (DATA.L), TKP (3479.T).
Is Xuanzhu Biopharmaceutical expensive compared with its peers?: On ev / sales it trades at 31.5× against a peer median of 3.5×, most expensive of 21 in its peer set.
How has Xuanzhu Biopharmaceutical stock performed?: Over six months to 6 Nov 2026 the shares returned -58.6% against -4.5% for the median peer; over one year -86.7%.